DNA Link, Inc. announced that it expects to receive KRW 5.000001012 billion in funding from Orbitech Co., Ltd.
September 24, 2023
Share
DNA Link, Inc. announced a private placement of 1,464,558 common shares for an issue price of KRW 3,1414 for gross proceeds of KRW 5,000,001,012 on September 25, 2023.The transaction will include participation from new investor Orbitech Co., Ltd. The transaction has been approved by board of directors of the company. The transaction is expected to close on November 13, 2023.
Orbitech Co., Ltd., formerly Korea NonDestructive Testing Co., Ltd., is Korea-based company engaged in the provision of nondestructive testing (NDT) and other services. The Company operates in four categories of businesses: NDT business, which provides NDT services for gas pipes, oil pipes, power plants, ships, bridges, buildings, vessel and tanks; nuclear energy business, which provides radiation-related services, such as radiation management, radiation protection and decontamination, and wastes management services for facilities and utilities; environment business, which provides process development services and analysis services, such as soil, water and marine waste analysis services, and in-service inspection (ISI) business, which provides ISI services used in nuclear power plant sector.
ORBITECH CO., LTD. 
